Translational research on Parkinson's disease and related disorders: Innovation of biomarkers, pathogenic mechanisms, and therapies

Chin-Song Lu
MD, Professor

A

Innovation of genetic biomarkers for Parkinson’s disease and related disorders using whole genome analysis and clinical translational research

Chin-Song Lu
MD, Professor

B

Development of molecular biomarkers for Parkinson's disease and related disorders

Tu-Hsueh Yeh
MD, PhD

C

Genetics analysis in Parkinson-related Dementia

Szu-Chia Lai
MD

D

Investigating cellular and molecular pathogenic mechanisms underlying mutant LRRK2-induced neurotoxicity of nigrostriatal system and physiological functions of LRRK2 in the brain using mutant LRRK2 knockin mice and LRRK2 knockout mice

Hong-Li Wang
PhD, Professor

E

Investigating therapeutic effects of LRRK2 inhibitors using PARK8 mouse
models

Yi-Hsin Weng
MD

F

Explore the role of dopamine D3 receptor and mTOR in l-dopa- and graft- induced dyskinesia in 6-OHDA-lesioned Parkinson mice model

Jin-Chung Chen
PhD, Professor